DK69991D0 - Heterocycliske acetyleniske aminer og deres anvendelse til fremstilling af laegemidler med indvirkning paa centralnervesystemet - Google Patents
Heterocycliske acetyleniske aminer og deres anvendelse til fremstilling af laegemidler med indvirkning paa centralnervesystemetInfo
- Publication number
- DK69991D0 DK69991D0 DK91699A DK69991A DK69991D0 DK 69991 D0 DK69991 D0 DK 69991D0 DK 91699 A DK91699 A DK 91699A DK 69991 A DK69991 A DK 69991A DK 69991 D0 DK69991 D0 DK 69991D0
- Authority
- DK
- Denmark
- Prior art keywords
- disorders
- nervous system
- central nervous
- preparation
- effect
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
- C07D207/09—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/30—Oxygen or sulfur atoms
- C07D233/32—One oxygen atom
- C07D233/36—One oxygen atom with hydrocarbon radicals, substituted by nitrogen atoms, attached to ring nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/70—One oxygen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Ophthalmology & Optometry (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Pyrrole Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US26367288A | 1988-10-27 | 1988-10-27 | |
PCT/US1989/003596 WO1990004588A1 (en) | 1988-10-27 | 1989-08-25 | Heterocyclic acetylenic amines having central nervous system activity |
Publications (2)
Publication Number | Publication Date |
---|---|
DK69991D0 true DK69991D0 (da) | 1991-04-18 |
DK69991A DK69991A (da) | 1991-04-18 |
Family
ID=23002777
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK069991A DK69991A (da) | 1988-10-27 | 1991-04-18 | Heterocycliske acetyleniske aminer og deres anvendelse til fremstilling af laegemidler med indvirkning paa centralnervesystemet |
Country Status (9)
Country | Link |
---|---|
US (1) | US5137905A (da) |
EP (2) | EP0605393A1 (da) |
JP (1) | JPH04501850A (da) |
KR (1) | KR900701758A (da) |
AT (1) | ATE134996T1 (da) |
AU (1) | AU636577B2 (da) |
DE (1) | DE68925906T2 (da) |
DK (1) | DK69991A (da) |
WO (1) | WO1990004588A1 (da) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5149705A (en) * | 1987-03-13 | 1992-09-22 | Allergan, Inc. | Acetylenes disubstituted with a heteroaromatic group and a tetralin group and having retinoid like activity |
US5550257A (en) * | 1991-04-24 | 1996-08-27 | American Cyanamid Company | Substituted oxotremorine derivatives |
RU2142461C1 (ru) * | 1991-08-14 | 1999-12-10 | Проктер энд Гэмбл Фармасьютикалз, Инк. | Циклические соединения мочевины, фармацевтическая композиция и способ лечения |
US5610294A (en) * | 1991-10-11 | 1997-03-11 | The Du Pont Merck Pharmaceutical Company | Substituted cyclic carbonyls and derivatives thereof useful as retroviral protease inhibitors |
USRE37781E1 (en) | 1991-10-11 | 2002-07-02 | Dupont Pharmaceuticals Company | Substituted cyclic carbonyls and derivatives thereof useful as retroviral protease inhibitors |
DE4414569A1 (de) * | 1994-04-27 | 1995-11-02 | Bayer Ag | Verwendung von substituierten Aminen zur Behandlung von Hirnleistungsstörungen |
ZA966885B (en) * | 1995-08-22 | 1998-02-16 | Du Pont Merck Pharma | Substituted cyclic ureas and derivatives thereof useful as retroviral protease inhibitors. |
CA2249617A1 (en) * | 1996-04-03 | 1997-10-09 | S. Jane Desolms | Inhibitors of farnesyl-protein transferase |
EP0818439B1 (en) * | 1996-07-02 | 1999-10-13 | Nisshin Flour Milling Co., Ltd. | Imide derivatives |
US6313110B1 (en) | 1999-06-02 | 2001-11-06 | Dupont Pharmaceuticals Company | Substituted 2H-1,3-diazapin-2-one useful as an HIV protease inhibitor |
NZ546887A (en) | 2003-11-03 | 2009-04-30 | Probiodrug Ag | Combinations useful for the treatment of neuronal disorders |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1218455B (de) * | 1964-01-30 | 1966-06-08 | Asta Werke Ag Chem Fab | Verfahren zur Herstellung von basisch substituierten cyclischen Harnstoffen und ihren Salzen |
GB1245743A (en) * | 1967-11-09 | 1971-09-08 | Astra Ab | Alkynyl lactams |
US4011238A (en) * | 1972-07-26 | 1977-03-08 | Gruppo Lepetit S.P.A. | 2-imidazolidione derivatives |
EP0426714B1 (en) * | 1988-07-25 | 1996-04-03 | The Upjohn Company | Acetylenic imidazoles having central nervous system activity |
US5001142A (en) * | 1989-07-19 | 1991-03-19 | American Cyanamid Company | 1-substituted-2-(3-amino-1-propynyl)pyrrolidine derivatives |
-
1989
- 1989-08-22 US US07/675,891 patent/US5137905A/en not_active Expired - Fee Related
- 1989-08-25 JP JP1509349A patent/JPH04501850A/ja active Pending
- 1989-08-25 AT AT89910266T patent/ATE134996T1/de active
- 1989-08-25 DE DE68925906T patent/DE68925906T2/de not_active Expired - Fee Related
- 1989-08-25 AU AU42109/89A patent/AU636577B2/en not_active Ceased
- 1989-08-25 WO PCT/US1989/003596 patent/WO1990004588A1/en active IP Right Grant
- 1989-08-25 KR KR1019900701364A patent/KR900701758A/ko not_active Application Discontinuation
- 1989-08-25 EP EP94101367A patent/EP0605393A1/en not_active Withdrawn
- 1989-08-25 EP EP89910266A patent/EP0440670B1/en not_active Expired - Lifetime
-
1991
- 1991-04-18 DK DK069991A patent/DK69991A/da not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
AU636577B2 (en) | 1993-05-06 |
JPH04501850A (ja) | 1992-04-02 |
AU4210989A (en) | 1990-05-14 |
US5137905A (en) | 1992-08-11 |
DK69991A (da) | 1991-04-18 |
EP0440670B1 (en) | 1996-03-06 |
KR900701758A (ko) | 1990-12-04 |
EP0605393A1 (en) | 1994-07-06 |
EP0440670A1 (en) | 1991-08-14 |
WO1990004588A1 (en) | 1990-05-03 |
DE68925906D1 (de) | 1996-04-11 |
ATE134996T1 (de) | 1996-03-15 |
DE68925906T2 (de) | 1996-08-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SE0104334D0 (sv) | Therapeutic agents | |
DK0613465T3 (da) | 1,3-Sustituerede cycloalkener og cycloalkaner med virkning på centralnervesystemet | |
ATE168007T1 (de) | Zur behandlung von erkrankungen des zentralnervensystems verwendbare benzimidazole | |
DK69991D0 (da) | Heterocycliske acetyleniske aminer og deres anvendelse til fremstilling af laegemidler med indvirkning paa centralnervesystemet | |
HK1007143A1 (en) | Benzoxazine compounds and pharmaceutical use thereof | |
DK0431580T3 (da) | Substituerede cyclohexanoler med virkning på centralnervesystemet | |
DK26289D0 (da) | Anvendelse af 1,4-disubstitueret piperidinyl til fremstilling af et farmaceutisk praeparat til behandling af insomnia | |
ES2060303T3 (es) | Derivados de piperidiloxiisoxazol y quinuclidiniloxiisoxazol, su preparacion y su uso terapeutico. | |
ATE63541T1 (de) | N-phenylethylaminoalkyl-benzamide als antiarrhythmische mittel. | |
KR880001596A (ko) | 디하이드로피리딘 화합물-함유 뇌기능이상 치료제 | |
DK38995A (da) | Acetyleniske imidazolderivater samt farmaceutisk præparat indeholdende disse | |
ATE81130T1 (de) | 4,5,6,7-tetrahydroisothiazolo (4,5-c)pyridinderivate und isomere. | |
DE68915595D1 (de) | Verwendung von Isoxazolinonen als cerebro-aktive Medikamente. | |
ATE147396T1 (de) | N-substituierte aminomethandiphosphonsäuren | |
ATE78482T1 (de) | Substituierte hexahydroarylchinolizine. | |
ATE108444T1 (de) | 3-isoxazolonderivate, ihre herstellung und ihre anwendung in der therapeutik. | |
TH9006A (th) | ซับสทิทิวเทด ไซโคลเฮกซีนต่าง ๆ ที่เป็นตัวสารสำหรับระบบระบบประสาทส่วนกลาง |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AHB | Application shelved due to non-payment |